Comparative Analysis of Humoral Immune Responses to HIV Type 1 Envelope Glycoproteins in Mice Immunized with a DNA Vaccine, Recombinant Semliki Forest Virus RNA, or Recombinant Semliki Forest Virus Particles-Reference-Cited by-同舟云学术

Comparative Analysis of Humoral Immune Responses to HIV Type 1 Envelope Glycoproteins in Mice Immunized with a DNA Vaccine, Recombinant Semliki Forest Virus RNA, or Recombinant Semliki Forest Virus Particles

Published:1998-10-10 Issue:15 Volume:14 Page:1369-1377
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

BRAND DENYS,LEMIALE FRANCK,TURBICA ISABELLE,BUZELAY LAURENCE,BRUNET SYLVIE,BARIN FRANCIS

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.1998.14.1369

Reference35 articles.

1. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160

2. Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences.

3. Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees

4. Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1

5. Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of self-amplifying mRNA technology in the development of infectious disease vaccines;Chinese Science Bulletin;2023-10-01

2. Advances in saRNA Vaccine Research against Emerging/Re-Emerging Viruses;Vaccines;2023-06-24

3. Vaccine development for zoonotic viral diseases caused by positive‑sense single‑stranded RNA viruses belonging to the Coronaviridae and Togaviridae families (Review);Experimental and Therapeutic Medicine;2022-11-30

4. The Delivery of mRNA Vaccines for Therapeutics;Life;2022-08-17

5. Therapeutic and prophylactic applications of self-replicating RNA viruses;Exploration of Immunology;2022-05-18